Sales & Marketing News | pharmaphorum

News

Tonix ends 16-year hiatus in fibromyalgia treatment

Tonix Pharma is preparing to launch a new therapy for fibromyalgia that analysts predict could make hundreds of millions of dollars in annual sales.

News

Novo Nordisk claims first GLP-1 approval in MASH

Under pressure from rivals in the GLP-1 space, Novo Nordisk has been given a leg-up with a first-in-class approval for Wegovy in liver disease MASH.

News

RFK Jr revives childhood vaccine task force

HHS Secretary Kennedy adds yet another layer of scrutiny to childhood vaccines with the re-establishment of a task force disbanded in the 1990s.

News

FDA clears Precigen's rare tumour immunotherapy

Precigen has won approval in the US for a first-in-class immunotherapy for recurrent respiratory papillomatosis, Papzimeos, its first product.

News

Trump orders stockpiling of essential medicine ingredients

Trump has ordered the creation of a six-month stockpile of ingredients to make essential medicines, in another part of his push to reshore production.

News

Under pressure from Trump, Lilly hikes Mounjaro prices in UK

Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro to bring it into parity with other European markets.

Tonix ends 16-year hiatus in fibromyalgia treatment

Novo Nordisk claims first GLP-1 approval in MASH

RFK Jr revives childhood vaccine task force

FDA clears Precigen's rare tumour immunotherapy

Trump orders stockpiling of essential medicine ingredients

Under pressure from Trump, Lilly hikes Mounjaro prices in UK

Compounded tirzepatide recalled after FDA warning

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks